08.30

Coffee

08.50-09.00

Welcome and introduction

Kimmo Porkka
Helsinki University Central Hospital

Session I: State of the art (chairs: K. Porkka, R. Lassila)

09.00-09.40

Coagulation in 2013

Robert Flaumenhaft
BIDMC/Harvard Medical School, Boston

09.40-10.20

Genetic markers in AML: will the promise of improving treatment outcomes be realized?

Charles Schiffer
Wayne State University School of Medicine, Detroit

10.20-10.40

Coffee, exhibitions

10.40-11.20

Curative therapy for mantle-cell lymphoma

Christian Geisler
Rigshospitalet, Copenhagen

11.20-12.00

Update on systemic mastocytosis

Peter Valent
Medical University of Vienna
 

12.00-13.00

Lunch, exhibitions

Session II: Finnish Leukemia Group therapy guidelines and studies

(chair: Marjatta Sinisalo)

13.00-13.30

 Neutropeeninen enterokoliitti

Maria Rämet, Tays

13.30-14.00

 Leukemiapotilaiden hemostaasiongelmat

Ulla Wartiovaara-Kautto, HUS
 

14.00-14.30

 Myeloomaryhmän tutkimus (FMG-MM02) ja  päivitystä ohjeistoon

Raija Silvennoinen, KYS

14.30-15.00

 Pneumokokkirokotukset hematologisilla potilailla

Vesa Lindström, HUS

15.30-16.00

FHRB-tilannekatsaus

Perttu Koskenvesa, HUS

16.00

 Tilaisuus päättyy